151 related articles for article (PubMed ID: 21072519)
1. Cytotoxic responses to N-(4-hydroxyphenyl)retinamide in human pancreatic cancer cells.
Messner MC; Cabot MC
Cancer Chemother Pharmacol; 2011 Aug; 68(2):477-87. PubMed ID: 21072519
[TBL] [Abstract][Full Text] [Related]
2. Increase of ceramide and induction of mixed apoptosis/necrosis by N-(4-hydroxyphenyl)- retinamide in neuroblastoma cell lines.
Maurer BJ; Metelitsa LS; Seeger RC; Cabot MC; Reynolds CP
J Natl Cancer Inst; 1999 Jul; 91(13):1138-46. PubMed ID: 10393722
[TBL] [Abstract][Full Text] [Related]
3. Dynamics of ceramide generation and metabolism in response to fenretinide--Diversity within and among leukemia.
Morad SA; Davis TS; Kester M; Loughran TP; Cabot MC
Leuk Res; 2015 Oct; 39(10):1071-8. PubMed ID: 26220867
[TBL] [Abstract][Full Text] [Related]
4. Fenretinide cytotoxicity for Ewing's sarcoma and primitive neuroectodermal tumor cell lines is decreased by hypoxia and synergistically enhanced by ceramide modulators.
Batra S; Reynolds CP; Maurer BJ
Cancer Res; 2004 Aug; 64(15):5415-24. PubMed ID: 15289350
[TBL] [Abstract][Full Text] [Related]
5. Synergistic cytotoxicity in solid tumor cell lines between N-(4-hydroxyphenyl)retinamide and modulators of ceramide metabolism.
Maurer BJ; Melton L; Billups C; Cabot MC; Reynolds CP
J Natl Cancer Inst; 2000 Dec; 92(23):1897-909. PubMed ID: 11106681
[TBL] [Abstract][Full Text] [Related]
6. Fenretinide (4-HPR) Targets Caspase-9, ERK 1/2 and the Wnt3a/β-Catenin Pathway in Medulloblastoma Cells and Medulloblastoma Cell Spheroids.
Bassani B; Bartolini D; Pagani A; Principi E; Zollo M; Noonan DM; Albini A; Bruno A
PLoS One; 2016; 11(7):e0154111. PubMed ID: 27367907
[TBL] [Abstract][Full Text] [Related]
7. Potential role of acid ceramidase in conversion of cytostatic to cytotoxic end-point in pancreatic cancer cells.
Morad SA; Messner MC; Levin JC; Abdelmageed N; Park H; Merrill AH; Cabot MC
Cancer Chemother Pharmacol; 2013 Mar; 71(3):635-45. PubMed ID: 23263160
[TBL] [Abstract][Full Text] [Related]
8. Dihydroceramide accumulation and reactive oxygen species are distinct and nonessential events in 4-HPR-mediated leukemia cell death.
Apraiz A; Idkowiak-Baldys J; Nieto-Rementería N; Boyano MD; Hannun YA; Asumendi A
Biochem Cell Biol; 2012 Apr; 90(2):209-23. PubMed ID: 22428532
[TBL] [Abstract][Full Text] [Related]
9. 4-oxo-fenretinide, a recently identified fenretinide metabolite, induces marked G2-M cell cycle arrest and apoptosis in fenretinide-sensitive and fenretinide-resistant cell lines.
Villani MG; Appierto V; Cavadini E; Bettiga A; Prinetti A; Clagett-Dame M; Curley RW; Formelli F
Cancer Res; 2006 Mar; 66(6):3238-47. PubMed ID: 16540676
[TBL] [Abstract][Full Text] [Related]
10. N-(4-hydroxyphenyl)retinamide elevates ceramide in neuroblastoma cell lines by coordinate activation of serine palmitoyltransferase and ceramide synthase.
Wang H; Maurer BJ; Reynolds CP; Cabot MC
Cancer Res; 2001 Jul; 61(13):5102-5. PubMed ID: 11431347
[TBL] [Abstract][Full Text] [Related]
11. Ceramide signaling in fenretinide-induced endothelial cell apoptosis.
Erdreich-Epstein A; Tran LB; Bowman NN; Wang H; Cabot MC; Durden DL; Vlckova J; Reynolds CP; Stins MF; Groshen S; Millard M
J Biol Chem; 2002 Dec; 277(51):49531-7. PubMed ID: 12388538
[TBL] [Abstract][Full Text] [Related]
12. N-(4-hydroxyphenyl)retinamide increases ceramide and is cytotoxic to acute lymphoblastic leukemia cell lines, but not to non-malignant lymphocytes.
O'Donnell PH; Guo WX; Reynolds CP; Maurer BJ
Leukemia; 2002 May; 16(5):902-10. PubMed ID: 11986953
[TBL] [Abstract][Full Text] [Related]
13. HIF-1α-dependent autophagy protects HeLa cells from fenretinide (4-HPR)-induced apoptosis in hypoxia.
Liu XW; Su Y; Zhu H; Cao J; Ding WJ; Zhao YC; He QJ; Yang B
Pharmacol Res; 2010 Nov; 62(5):416-25. PubMed ID: 20637870
[TBL] [Abstract][Full Text] [Related]
14. p75 neurotrophin receptor and fenretinide-induced signaling in neuroblastoma.
Ganeshan VR; Schor NF
Cancer Chemother Pharmacol; 2014 Feb; 73(2):271-9. PubMed ID: 24253178
[TBL] [Abstract][Full Text] [Related]
15. 4-oxo-N-(4-hydroxyphenyl)retinamide: two independent ways to kill cancer cells.
Tiberio P; Cavadini E; Abolafio G; Formelli F; Appierto V
PLoS One; 2010 Oct; 5(10):e13362. PubMed ID: 20976277
[TBL] [Abstract][Full Text] [Related]
16. Cytotoxicity and molecular activity of fenretinide and metabolites in T-cell lymphoid malignancy, neuroblastoma, and ovarian cancer cell lines in physiological hypoxia.
Song MM; Makena MR; Hindle A; Koneru B; Nguyen TH; Verlekar DU; Cho H; Maurer BJ; Kang MH; Reynolds CP
Anticancer Drugs; 2019 Feb; 30(2):117-127. PubMed ID: 30272587
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of synergy of N-(4-hydroxyphenyl)retinamide and ABT-737 in acute lymphoblastic leukemia cell lines: Mcl-1 inactivation.
Kang MH; Wan Z; Kang YH; Sposto R; Reynolds CP
J Natl Cancer Inst; 2008 Apr; 100(8):580-95. PubMed ID: 18398104
[TBL] [Abstract][Full Text] [Related]
18. N-(4-Hydroxyphenyl)retinamide (4-HPR) induces leukemia cell death via generation of reactive oxygen species.
Goto H; Takahashi H; Fujii H; Ikuta K; Yokota S
Int J Hematol; 2003 Oct; 78(3):219-25. PubMed ID: 14604280
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of N-(4-hydroxyphenyl)retinamide-induced autophagy at a lower dose enhances cell death in malignant glioma cells.
Tiwari M; Bajpai VK; Sahasrabuddhe AA; Kumar A; Sinha RA; Behari S; Godbole MM
Carcinogenesis; 2008 Mar; 29(3):600-9. PubMed ID: 18174255
[TBL] [Abstract][Full Text] [Related]
20. Involvement of c-Fos in fenretinide-induced apoptosis in human ovarian carcinoma cells.
Appierto V; Villani MG; Cavadini E; Lotan R; Vinson C; Formelli F
Cell Death Differ; 2004 Mar; 11(3):270-9. PubMed ID: 14647238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]